Get updates to this list
You’re signing up to all partnering opportunity alerts for:
Please check your inbox
Thank you for verifying your email. We have sent you a confirmation email containing a 6 digit verification code to complete your subscription
You've successfully created a subscription
The search results below each have a summary which you may find useful
in determining if the opportunity is what you’re looking for.
generated. This would enable more complicated biological molecules to be generated at the higher volumes and better quality required to bring down costs and make more of these therapeutics available. This would especially be the case for more
There have been many innovations in the treatment of cancer one of which has been the use of antibody-drug conjugates (ADCs) where antibodies that target markers on cancer cells are linked to chemotherapy drugs.... more
generation biologics based on its two patented transgenic mouse platforms for producing fully human antibodies.
Therapeutic monoclonal antibody (mAb) is one of the fastest growing segments of the global pharmaceutical... more
Antibody-drug conjugates (ADCs) are a promising method of treating cancer where antibodies that target markers on cancer cells are linked to chemotherapy drugs. This enables the drug to be delivered to the cancer... more
administration of a GD2-specific CAR-T cell or CAR-NK cell or a GD2 specific antibody to the subject. Further, the present invention relates to a GD2-specific CAR-T cell or CAR-NK cell or a GD2-specific more
Chimeric antigen receptors (CARs) have been developed for the molecular engineering of effector T-cells to be used in targeted cancer therapy. CARs consist of the antigen-binding single-chain fragment (scFv) of an antibody... more
), human cytomegalovirus (HCMV) and human (mostly) and mouse lymphocytes receptors and their ligands.
The database is a collection of monoclonal antibodies (mAbs). For most of the targeted proteins, there is no other antibody... more
this technology is in terms of the cost compared to the high-cost norovirus concentration method which uses an expensive antibody.
Therefore, under commercial agreement with technical assistance and license... more
innovative technology takes advantage of magnetic nanoparticles coated with a monoclonal antibody that are injected into the bloodstream via an intravenous cannula, as well as of a special wire containing a magnetic... more
could be an industry blockbuster. The platform enables the discovery and development of new biopharmaceuticals, enzymes and high production cell lines. The system will be fully-automated and can be integrated into various antibody... more
therapeutic purposes. In particular when coupled to a drug, the aptamer may be used in analogy to an antibody-drug-conjugate.
The offer addresses companies from the pharmaceutical or biotechnology sector that... more
protein, antibody, or amino acid.)
The developed sensor provides very specific properties due to its special geometry, which allows the transformation of the whole or of only a part of a normal or of an oblique... more
partner will develop together a proof of concept.
There are many applications such as vaccine development, antibody development, screening&diplay, in vitro diagnotics, structural biology and protein vectorization.
materials throughout years of research and offers their expertise to potential partners for tailored applications.
(3) Bioanalysis (antibody-antigen interactions, etc.) and determination of pH, temperature, oxygen,... more